Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int Ophthalmol ; 38(6): 2609-2616, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29086326

RESUMO

PURPOSE: To report a farmer's corneal abscess caused by an unusual pathogen: Listeria monocytogenes fluoroquinolone resistant. METHODS: A 78-year-old farmer presented a central corneal abscess associated with 1-mm hypopyon and decreased visual acuity evolving since 2 weeks. First an antibiotic therapy associating oral ofloxacin and topical ciprofloxacin, vancomycin and ceftazidime was started. Different samples of the abscess were performed and sent to different microbiological laboratories. RESULT: Listeria monocytogenes was isolated after 2 days of culture. Antibiotics sensitivity showed resistance to ciprofloxacin, fosfomycin and fusidic acid. Ceftazidime was changed for gentamicin, and after 1 month of treatment the abscess decreased considerably. CONCLUSION: This case demonstrated that even if Listeria is rarely involved in ocular abscess, it must be evocated for people with risk factors as farmers. This suspicion should lead to an extended incubation to identify the pathogen. The analysis of Listeria resistance is essential to start an efficient therapy.


Assuntos
Abscesso/microbiologia , Doenças da Córnea/microbiologia , Listeria monocytogenes/isolamento & purificação , Listeriose/diagnóstico , Idoso , Antibacterianos/uso terapêutico , Humanos , Resultado do Tratamento
2.
J Immunother ; 40(2): 77-82, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28166182

RESUMO

Vogt-Koyanagi-Harada (VKH) syndrome is a rare condition implicating systemic immune reaction against melanocytes. The pathophysiology is unclear. A genetic predisposition has been suggested as HLA-DR4/DRB1*04 is more common among VKH patients. Drug induced VKH syndrome has been reported in advanced melanoma patients receiving immunotherapy, including ipilimumab and adoptive cell transfer of Tumor-Infiltrating Lymphocyte associated with IL-2. To date, no case of anti PD-1 -induced VKH syndrome has been described. We report here the case of a HLA-DR4/DRB1*04 patient successfully treated with anti PD-1 for advanced melanoma who developed a systemic immune reaction against melanocytes for whom we discuss a VKH-like syndrome diagnosis in a potentially genetically predisposed patient.


Assuntos
Anticorpos Monoclonais Humanizados/uso terapêutico , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/diagnóstico , Imunoterapia/métodos , Melanoma/tratamento farmacológico , Meningite Asséptica/diagnóstico , Neoplasias Cutâneas/tratamento farmacológico , Uveíte/diagnóstico , Síndrome Uveomeningoencefálica/diagnóstico , Resistencia a Medicamentos Antineoplásicos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/genética , Predisposição Genética para Doença , Antígeno HLA-DR4/genética , Cadeias HLA-DRB1/genética , Humanos , Imunoterapia/efeitos adversos , Metástase Linfática , Masculino , Melanócitos/imunologia , Melanoma/secundário , Meningite Asséptica/etiologia , Meningite Asséptica/genética , Pessoa de Meia-Idade , Receptor de Morte Celular Programada 1/imunologia , Neoplasias Cutâneas/secundário , Uveíte/etiologia , Uveíte/genética , Síndrome Uveomeningoencefálica/etiologia , Síndrome Uveomeningoencefálica/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...